Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Steri3X for Prevention of Post-operative Wound Infections in Cesarean Sections

NCT05392400 is registered in ClinicalTrials.gov with University of Tennessee as lead sponsor.

NCT NCT05392400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05392400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Steri3X for Prevention of Post-operative Wound Infections in Cesarean Sections
Lead sponsor
University of Tennessee
Phase
Phase 2
Overall status
Unknown status
Start date
February 7, 2023
Completion date
February 7, 2024
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section; complications, wound, infection (following delivery), postpartum complication, surgical site infection